What it sells
Clinical-grade operating infrastructure for independent aesthetic practices.
Business model breakdown
Buyer: who owns the budget?
UnverifiedPractice owner / medical director.
Trigger: what makes them buy now?
Aspiring or growing independent medspa owners hitting red tape and high costs to launch and run a practice.
Workflow: what inputs become what output?
Online booking and intake, charting/treatment plans, payments and financing (BNPL), compliance, marketing, medical director matching, inventory.
Economics: what it saves and how it charges
Software plus services; claims up to 55% savings on injectables/devices, 25 hrs/week saved, 10% higher margins vs industry.
Distribution: how it reaches customers
Free strategy call / demo-led sales; community (Scale Society).
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-03-10 | Series C | $25M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.